| Fiscal Period | 2024 | 2023 | 2022 |
|---|---|---|---|
| Period End Date | Mar 24 | Mar 23 | Mar 22 |
| Cash Equivalents | 47.02 | - | - |
| Short Term Investments | 263.15 | 282.61 | 99.42 |
| Cashand Short Term Investments | 310.18 | 538.58 | 352.54 |
| Accounts Receivable- Trade Net | 349.61 | 297.25 | 215.56 |
| Total Receivables Net | 349.61 | 471.76 | 269.03 |
| Total Inventory | 207.95 | 0.13 | 0.54 |
| Other Current Assets Total | 28.49 | 51.93 | 179.34 |
| Total Current Assets | 896.23 | 1,062.40 | 801.45 |
| Property/ Plant/ Equipment Total- Net | 786.48 | 47.00 | 15.98 |
| Intangibles Net | 0.32 | 127.98 | 71.16 |
| Long Term Investments | 7.03 | - | - |
| Note Receivable- Long Term | 2.67 | 12.56 | 0.80 |
| Other Long Term Assets Total | 7.98 | 22.71 | 24.46 |
| Total Assets | 1,700.71 | 1,706.87 | 948.27 |
| Accounts Payable | 94.44 | 100.65 | 88.25 |
| Current Portof LT Debt/ Capital Leases | 7.85 | 27.30 | 11.02 |
| Other Currentliabilities Total | 39.87 | 474.65 | 271.91 |
| Total Current Liabilities | 142.16 | 629.81 | 400.75 |
| Long Term Debt | 0.00 | 91.63 | 0.00 |
| Capital Lease Obligations | 1.89 | 9.95 | 0.79 |
| Total Long Term Debt | 1.89 | 101.59 | 0.79 |
| Total Debt | 9.74 | 128.89 | 11.81 |
| Deferred Income Tax | 28.06 | 1.40 | 1.54 |
| Other Liabilities Total | 1.96 | 203.79 | 0.00 |
| Total Liabilities | 174.06 | 936.59 | 403.08 |
| Common Stock Total | 10.46 | 26.91 | 115.56 |
| Other Equity Total | 1,516.18 | - | - |
| Total Equity | 1,526.65 | 770.29 | 545.19 |
| Total Liabilities Shareholders' Equity | 1,700.71 | 1,706.87 | 948.27 |
| Total Common Shares Outstanding | 10.46 | 13.46 | 13.46 |
| Tangible Book Valueper Share Common Eq | 145.90 | 15.46 | 32.66 |
| Cash | - | 255.97 | 253.12 |
| Property/ Plant/ Equipment Total- Gross | - | 84.36 | 53.27 |
| Accumulated Depreciation Total | - | -37.36 | -37.28 |
| Goodwill Net | - | 434.23 | 34.42 |
| Accrued Expenses | - | 27.21 | 29.57 |
| Notes Payable/ Short Term Debt | - | 0.00 | 0.00 |
| Retained Earnings( Accumulated Deficit) | - | 743.37 | 429.63 |
Concord Biotech Dividend Concord Biotech Bonus Concord Biotech News Concord Biotech AGM Concord Biotech Rights Concord Biotech Splits Concord Biotech Board Meetings Concord Biotech Key Metrics Concord Biotech Shareholdings Concord Biotech Profit Loss Concord Biotech Cashflow Concord Biotech Q1 Results Concord Biotech Q2 Results Concord Biotech Q3 Results Concord Biotech Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks